Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Novozymes, ThioLogics In Conjugation Platform Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Novozymes, ThioLogics In Conjugation Platform Pact

To offer serum-stable drug-albumin conjugation capability

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Novozymes Biopharma has partnered with ThioLogics to offer serum-stable drug-albumin conjugation capabilities. The collaboration combines Novozymes’ modified recombinant human albumin (rAlbumin) Veltis technology, with ThioLogics’ site-specific maleimide conjugation platform, allowing Novozymes to offer serum stable albumin drug conjugates with enhanced pharmacokinetic and/or targeting capabilities. 
 
“Combining the benefits of Novozymes’ and ThioLogics’ technology platforms means that we can now work with more customers across a wider range of drug candidates,” said, Dermot Pearson, marketing director at Novozymes Biopharma. He continues, “Together we are creating new opportunities for customers by providing them with a single access point to link Novozymes’ Veltis albumins and ThioLogics’ conjugation platform, to improve their products.
  
“We are delighted to announce ThioLogics’ unique collaboration with Novozymes, which will expand the capabilities of our technology platform beyond antibody drug conjugates,” said Dr. Chris Williams, business development manager at ThioLogics.
 
Novozymes also recently partnered with Almac in the field of drug conjugation to support the use of the Veltis platform in peptide and protein fusion.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics